Evidence map›Paper›PMID 41003928›Full record

ArticleAMB Express2025

Phage receptor binding protein and Fc fragment fusion enhances phagocytosis of Y. enterocolitica.

Karolina Filik-Matyjaszczyk, Irwin Matyjaszczyk, Marzena Ciesielska, Bożena Szermer-Olearnik, Krzysztof Mikołajczyk, Andrzej Gamian

Abstract read
In one paragraph

Article in AMB Express, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Review
  3. Genomic characterization ofFrontiers in microbiology · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Karolina Filik-MatyjaszczykHirszfeld Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, 53-114, Wroclaw, Poland. karolina.filik@hirszfeld.pl.
Irwin MatyjaszczykDepartment of Biochemistry, Selvita S.A, 30-394, Cracow, Poland.
Marzena CiesielskaHirszfeld Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, 53-114, Wroclaw, Poland.
Bożena Szermer-OlearnikHirszfeld Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, 53-114, Wroclaw, Poland.
Krzysztof MikołajczykHirszfeld Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, 53-114, Wroclaw, Poland.
Andrzej GamianHirszfeld Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, 53-114, Wroclaw, Poland.

Funding

Narodowe Centrum Nauki DEC-2023/07/X/NZ6/00118
6 · The paper itself

Abstract

Bacteriophage receptor binding proteins (RBPs) belong to a group of proteins that are components of the bacteriophage tail. RBPs are mainly responsible for recognizing receptors on the bacterial host surface and enabling infection and subsequent progeny phage multiplication. Our previous research suggested that recombinant tail fiber gp17 (TFPgp17) protein from Yersinia enterocolitica phage φYeO3-12 recognizes serotype O:3 with high specificity and could be used as a diagnostic tool. In this paper, we study the possibility of using modified TFPgp17 in fusion with IgG1 Fc immunoglobulin fragment (Fc_TFPgp17) to improve the efficacy of pathogen recognition by phagocytic cells, opsonization of bacterial cells, and then phagocytosis by the THP-1 macrophages and the HL-60 neutrophils. We demonstrate that the Fc_TFPgp17 protein can bind both bacterial and phagocytic cells, due to the presence of the RBP domain and the IgG1 Fc fragment, respectively. Additionally, it contributes to the better recognition of bacterial cells and their subsequent phagocytosis by phagocytes. Additionally, we proved that glycosylation of Fc_TFPgp17 which occurred during protein production, harms the ability to recognize Y. enterocolitica O:3. Fc_TFPgp17 is a bispecific protein that possesses two biological functions: (I) recognized Y. enterocolitica O:3 cells via phage RBP (TFPgp17) and (II) recognized phagocytic cells via Fc-fragment IgG1 immunoglobulin. In this work, we demonstrated that the recombined bispecific protein facilitates more effective recognition and opsonization of the pathogenic bacterial cell, leading to its subsequent phagocytosis.

Indexed as

ImmunotherapyMacrophagesNeutrophilsPhagocytosisRBPYersinia Enterocolitica

Identifiers

PMID41003928
PMCPMC12474815

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.